GlassScriptPhysician profile
Song C Chon
NPI 1821069204
$26,350.61
in general payments reported to CMS, 2019-2025
44 companies · $4,911 in 2025
The $4,911 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,131 · 2020: $2,451 · 2021: $3,281 · 2022: $3,628 · 2023: $4,362 · 2024: $4,586 · 2025: $4,911.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,181.28 |
| Education | $677.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,742.68 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $3,856.94 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $1,870.84 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,489.34 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $1,313.93 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Jazz Pharmaceuticals INC. | $1,272.68 | 2019-2024 | Xywav |
| Grifols USA, LLC | $1,239.88 | 2019-2025 | Prolastin-C Liquid, Gamunex-C |
| Takeda Pharmaceuticals U.S.A., INC. | $1,191.20 | 2020-2025 | Glassia, Cuvitru |
| Mallinckrodt Hospital Products INC. | $1,073.87 | 2020-2025 | Acthar |
| Harmony Biosciences LLC | $995.81 | 2020-2025 | Wakix |
| Mylan Specialty L.P. | $890.65 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $758.02 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $728.80 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Amgen INC. | $596.01 | 2022-2025 | Tezspire |
| Ani Pharmaceuticals, INC. | $459.33 | 2022-2024 | Purified Cortrophin Gel |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $398.34 | 2019-2025 | Arikayce, Brinsupri |
| Electromed, INC. | $374.24 | 2022-2025 | Smartvest |
| Axsome Therapeutics, INC. | $358.98 | 2023-2025 | Sunosi |
| Philips North America LLC | $347.75 | 2019-2024 | (Ak6) Vest Therapy |
| Baxter Healthcare | $290.91 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Sanofi-Aventis U.S. LLC | $254.89 | 2022-2025 | |
| Genentech USA, INC. | $226.63 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $186.22 | 2020-2023 | Belsomra |
| Mallinckrodt Enterprises LLC | $183.90 | 2019 | |
| Verona Pharma, INC. | $164.26 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $145.11 | 2025 | Yupelri |
| Sunovion Pharmaceuticals INC. | $141.87 | 2019 | |
| Shire North American Group INC | $111.17 | 2019 | |
| Inogen, INC. | $100.25 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Pfizer INC. | $99.18 | 2019-2024 | |
| Advanced Respiratory, INC | $86.80 | 2019-2021 | |
| Vifor Pharma, INC. | $56.82 | 2024-2025 | Zemaira, Veltassa |
| Csl Behring | $52.39 | 2020-2024 | Hizentra |
| Teva Pharmaceuticals USA, INC. | $46.47 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $46.00 | 2021-2022 | |
| Resmed Corp | $36.26 | 2019-2024 | |
| Vapotherm INC | $24.98 | 2021 | |
| Fisher & Paykel Healthcare INC | $23.40 | 2019 | |
| Lilly USA, LLC | $22.89 | 2025 | Zepbound |
| Optinose US, INC. | $21.52 | 2020 | |
| Nabriva Therapeutics, Plc | $18.34 | 2021 | |
| Gilead Sciences, INC. | $18.04 | 2024 | Veklury |
| Pulmonx Corporation | $16.67 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Azurity Pharmaceuticals, INC. | $16.35 | 2023 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Song Chon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.